| Molecular formula | C63H98N18O13S |
| Molecular weight | 1347.6 g/mol |
| Registered trials | 1147 |
| PubChem CID | 36511 |
What Substance P Is
Substance P is a peptide with the molecular formula C63H98N18O13S and a molecular weight of approximately 1347.6 (PubChem CID 36511). It has no FDA-approved label, no approved brand name, and no approved indications. It is classified here as an unapproved, investigational research compound, meaning any use outside registered research settings falls outside regulatory oversight.
Trial Footprint
Substance P appears in 1,147 registered clinical trials. Sampled studies span a range of contexts and stages, from a not-yet-recruiting global health research center study (NCT07582380) to a Phase 4 investigation of cerebral flow-metabolism coupling during adult surgery (NCT05941494, status unknown). Another listed study is actively recruiting participants to examine signatures of Alzheimer's disease in subjective cognitive decline (NCT07402161). These entries reflect registration activity and status at the time of data retrieval, not confirmed outcomes or established efficacy.
FAQ
No. Substance P has no FDA-approved label, brand name, or approved indication. It is classified as an unapproved research compound.
It appears across 1,147 registered clinical trials covering varied topics, including surgical monitoring and cognitive decline research. These are registered studies, not confirmed treatment uses.
Substance P is a peptide with the molecular formula C63H98N18O13S and a molecular weight of about 1347.6. It is catalogued under PubChem CID 36511.
No adverse event report data was available for this compound at the time of review. This does not mean side effects do not exist, only that no such data was provided here.
These are standard clinical trial registry statuses. 'Not yet recruiting' means the study has not begun enrolling participants, while 'unknown' means the registry has not confirmed the study's current status.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 36511 ClinicalTrials.gov registry data (retrieved 2026-09-19)
Updated 2026-09-19